Intervention Review
You have free access to this content
Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)
Editorial Group: Cochrane Heart Group
Published Online: 16 JUL 2008
Assessed as up-to-date: 12 SEP 2010
DOI: 10.1002/14651858.CD004102.pub2
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Database Title
Additional Information
How to Cite
Vallejo M, Reyes PPA. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD004102. DOI: 10.1002/14651858.CD004102.pub2.
Publication History
- Publication Status: New search for studies and content updated (no change to conclusions)
- Published Online: 16 JUL 2008
Cited in:
- CrossRef
This article has been cited by:
- 1
- 2, , , Coronary heart disease patients’ perception of their symptoms and sense of control are associated with their quality of life three years following hospital discharge, Journal of Clinical Nursing, 2009, 18, 1Direct Link:
- 3, , , , Consideraciones sobre la enfermedad de Chagas en España, Medicina ClÃnica, 2008, 131, 1, 37
- 4, Reply, Journal of Travel Medicine, 2008, 15, 5Direct Link:
- 5, , , Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy, The Cochrane Library,Direct Link:
